Although recent retrospective clinical studies have suggested that the overexpression of romo1 can be a diagnostic and prognostic marker for non-small cell lung cancer (NSCLC) [2, 9, 10], conclusive evidence is lacking. Here, ROMO1 is linked to non-small cell lung carcinoma.